RP

Raghuvendra Pratap Singh

Active Director Director DIN 09402389
DIN 09402389 First appointment Nov 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Raghuvendra Pratap Singh

Data last updated:

Raghuvendra Pratap Singh is a Director at Young India Healthcare And Research Private Limited (since 2021). The company operates in Healthcare.

DIN 09402389
Primary Designation Director
Industry Healthcare
First Appointment 17 Nov 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Nov 20212021Active

Directorship timeline

Open interactive timeline →
Young India Healthcare And Research Private Limited
Premium access

Shareholding and investment profile for Raghuvendra Pratap Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raghuvendra Pratap Singh

Raghuvendra Pratap Singh currently holds 1 directorship: Young India Healthcare And Research Private Limited (Director, since 17 Nov 2021).

Raghuvendra Pratap Singh was first appointed on 17 Nov 2021 as Director at Young India Healthcare And Research Private Limited.

The current boards of Raghuvendra Pratap Singh's companies include Charan Singh (Young India Healthcare And Research Private Limited), Swati Thakur (Young India Healthcare And Research Private Limited), Usha Devi (Young India Healthcare And Research Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available